Vertex Pharmaceuticals Incorporated (VRTX) Stock Analysis | Financial Data & Charts

Investment Radar

Seven-Dimensional Value Assessment Based on 2025 Q4 Financials

加载雷达图...

加载图表中...

📊 Valuation

Key valuation metrics

EV/EBITDA (TTM)

i

Enterprise Value, EBITDA and Ratio

EV/EBIT (TTM)

i

Enterprise Value, EBIT and Ratio

EV/Sales (TTM)

i

Enterprise Value, Revenue and Ratio

P/E Ratio (TTM)

i

Market Cap, Net Income and Ratio

P/B Ratio (Quarterly)

i

Market Cap, Book Value and Ratio

FCF Yield (TTM)

i

FCF, Enterprise Value and Yield

PR Profit Ratio (PPM)

i

PE Ratio, ROE and Profit Ratio (PR = PE / ROE)

📈 Growth

Revenue, earnings, and per-share growth metrics

Revenue (Quarterly)

i

Quarterly Revenue

Revenue/Share (Quarterly)

i

Revenue Per Share

Net Income (Quarterly)

i

Quarterly Net Income

EPS (Quarterly)

i

Earnings Per Share

Gross Profit/Share (Quarterly)

i

Gross Profit Per Share

OCF/Share (Quarterly)

i

Operating Cash Flow Per Share

FCF/Share (Quarterly)

i

Free Cash Flow Per Share

Operating Leverage (YoY)

i

Change in Operating Income / Change in Revenue

💰 Profitability

Profit margins and return on equity

Gross Margin (TTM)

i

Revenue, Gross Profit and Gross Margin

Operating Margin (TTM)

i

Revenue, Operating Income and Operating Margin

Net Profit Margin (TTM)

i

Revenue, Net Income and Net Profit Margin

ROE (TTM)

i

Equity, Net Income and Return on Equity

ROA (TTM)

i

Assets, Net Income and Return on Assets

ROTCE - Return on Tangible Common Equity (TTM)

i

Net Income, Tangible Common Equity and ROTCE

OCF Margin (TTM)

i

Revenue, Operating Cash Flow and OCF Margin

FCF Margin (TTM)

i

Revenue, Free Cash Flow and FCF Margin

💵 Cash Quality

Cash flow quality and conversion metrics

OCF/NI Ratio (TTM)

i

Operating Cash Flow, Net Income and Ratio

FCF/NI Ratio (TTM)

i

Free Cash Flow, Net Income and Ratio

OCF/Capex (TTM)

i

Operating Cash Flow, Capex and Coverage Ratio

OCF/SBC (TTM)

i

Operating Cash Flow, SBC and Coverage Ratio

🛡️ Leverage & Liquidity

Debt, liquidity, and financial health

Debt/Equity (quarterly)

i

Total Debt, Total Equity and Debt/Equity Ratio

EBITDA/Net Debt (TTM)

i

EBITDA, Net Debt and Coverage Ratio

Interest Coverage (TTM)

i

EBIT, Interest Expense and Coverage Ratio

Current Ratio (quarterly)

i

Current Assets, Current Liabilities and Current Ratio

Quick Ratio (quarterly)

i

Quick Assets, Current Liabilities and Quick Ratio

Altman Z-Score

i

Financial Distress Prediction Model

⚙️ Ops & Cap Efficiency

Asset utilization, working capital, ROIC, and capital efficiency

ROIC (TTM)

i

NOPAT, Invested Capital and Return on Invested Capital

ROCE - Return on Capital Employed (TTM)

i

EBIT, Capital Employed and Return on Capital Employed

Asset Turnover (TTM)

i

Revenue, Total Assets and Turnover Ratio

CapEx/Depreciation - Investment Intensity (TTM)

i

CapEx, Depreciation and Ratio (>1=Expansion, <1=Contraction)

R&D/Gross Profit - R&D Intensity (TTM)

i

R&D Expenses, Gross Profit and Ratio

SG&A/Revenue - SG&A Efficiency (TTM)

i

SG&A Expenses, Revenue and Ratio

Cash Conversion Cycle (TTM)

i

DSO + DIO - DPO (in days)

DSO - Days Sales Outstanding (TTM)

i

Average Receivables and Days Sales Outstanding

DIO - Days Inventory Outstanding (TTM)

i

Average Inventory and Days Inventory Outstanding

DPO - Days Payables Outstanding (TTM)

i

Average Payables and Days Payables Outstanding

Goodwill/Assets (Quarterly)

i

Goodwill as % of Total Assets

🎁 Shareholder Returns

Dividends, share buybacks, dilution, and insider trading activity

Dividend Yield (TTM)

i

Dividend Per Share, Share Price and Dividend Yield

Buyback Yield (TTM)

i

Net Buyback and Buyback Yield

Buyback Yield (3 Years)

i

Net Buyback 3Y and Buyback Yield 3Y

Dilution Rate (1 Year)

i

Current Shares, 1Y Ago Shares and Dilution Rate

Dilution Rate (3 Years)

i

Current Shares, 3Y Ago Shares and Dilution Rate

SBC Offset Rate (TTM)

i

Buyback / Stock-Based Comp and SBC Ratio

Insider Activity Rate (TTM)

i

Insider Net Buying and Activity Rate

Profit Waterfall Analysis

加载图表中...

P

Profitability Margins

Gross Profit Margini

85.56%

Gross Profit = $2.76B

Revenue = $3.23B

Operating Profit Margini

40.30%

Operating Income = $1.30B

Revenue = $3.23B

EBITDA Margini

41.94%

EBITDA = $1.35B

Revenue = $3.23B

EBIT Margini

40.30%

EBIT = $1.33B

Revenue = $3.23B

Net Profit Margini

36.91%

Net Income = $1.19B

Revenue = $3.23B

Pretax Profit Margini

41.24%

EBT = $1.33B

Revenue = $3.23B

E

Operating Efficiency

Interest Coveragei

347.56x

EBIT (TTM) = $4.62B

Interest Expense (TTM) = $0.01B

9.1x

-11.9x

258.3x

348.6x

347.6x

SG&A / Revenuei

15.09%

SG&A = $0.49B

Revenue = $3.23B

R&D / Revenuei

30.17%

R&D = $0.97B

Revenue = $3.23B

R

Return Metrics (TTM)

ROAi

16.24%

Net Income = $3.95B

Avg Total Assets = $24.34B

ROEi

22.54%

Net Income = $3.95B

Avg Equity = $17.54B

ROICi

42.58%

NOPAT (TTM) = $3.63B

Avg Invested Capital = $8.53B

(NOPAT = Operating Income × (1 - Effective Tax Rate))

(Avg IC = (Current IC + Year-Ago IC) / 2)

Revenue Growthi

10.82%

Current Revenue = $3.23B

Previous Revenue = $2.91B

+15.7%

+3.1%

+12.1%

+11.0%

+10.8%

Operating Cash Flow/Sharei

$14.18

Operating CF = $3.63B

Diluted Shares = 0.26B

$-1.89

$-3.78

$14.86

$14.43

$14.18

Comprehensive Analysis

Income Statement Items	YoY Growth	Current Quarter Value	Trend
Revenue	+10.8%	$3.23B	↑
Gross Profit	+10.9%	$2.76B, 85.56%	↑
Operating Income	+26.7%	$1.30B, 40.30%	↑
EBITDA	+14.3%	$1.35B, 41.94%	↑
EBT	+17.1%	$1.33B, 41.24%	↑
Net Income	+30.5%	$1.19B, 36.91%	↑
Diluted EPS	+32.9%	4.65	↑

加载图表中...

L

Liquidity Metrics

Current Ratioi

2.90

Healthy

Total Current Assets = $11.20B

Total Current Liabilities = $3.86B

Quick Ratioi

2.44

Healthy

Quick Assets = $9.51B

Total Current Liabilities = $3.86B

Cash Ratioi

1.71

Healthy

Cash & Equivalents = $6.61B

Total Current Liabilities = $3.86B

Cash Ratio = (Cash + Short-term Investments) / Current Liabilities

L

Leverage Metrics

Debt to Equityi

0.21

Healthy

Total Debt = $3.88B

Total Equity = $18.67B

Liabilities to Assetsi

28.6%

Healthy

Total Liabilities = $7.48B

Total Assets = $26.14B

Equity Multiplieri

1.40

Healthy

Total Assets = $26.14B

Total Equity = $18.67B

E

Efficiency Metrics

Asset Turnoveri

0.49

Attention

Revenue (TTM) = $12.04B

Avg Total Assets = $24.34B

Inventory Turnoveri

1.00

Attention

COGS (TTM) = $1.65B

Avg Inventory = $1.66B

Receivables Turnoveri

6.02

Normal

Revenue (TTM) = $12.04B

Avg Receivables = $2.00B

S

Solvency Metrics

Interest Coveragei

347.56

Healthy

EBIT (TTM) = $4.62B

Interest Expense (TTM) = $0.01B

Net Debt to EBITDAiNet Debt/EBITDA

-0.25

Healthy

Net Debt = $-1.21B

EBITDA (TTM) = $4.91B

Debt Service Coveragei

38.14

Healthy

Operating CF (TTM) = $3.63B

Debt Service = $0.10B

V

Value Metrics

Goodwill %iGoodwill/Assets

4.2%

Healthy

Goodwill = $1.09B

Total Assets = $26.14B

Working Capital Ratioi

0.28

Healthy

Working Capital = $7.34B

Total Assets = $26.14B

加载图表中...

Cash Flow Waterfall Chart

加载图表中...

Inflow

Outflow

Subtotal

Start/End

C

Cash Flow Metrics

Operating Cash Flow TTMi

$3.63B

Free Cash Flow TTMi

$3.19B

FCF = OCF - CapEx

OCF (TTM) = $3.63B

CapEx (TTM) = $-0.44B

FCF Yieldi

2.71%

Attention

FCF (TTM) = $3.19B

Market Cap = $118.07B

OCF/Sales Ratioi

30.17%

Healthy

OCF (TTM) = $3.63B

Revenue (TTM) = $12.04B

Q

Quality & Coverage Metrics

Income Qualityi

0.92x

Attention

OCF (TTM) = $3.63B

Net Income (TTM) = $3.95B

Cash Flow/Debti

0.94x

Healthy

OCF (TTM) = $3.63B

Total Debt = $3.88B

Short Term Coveragei

0.94x

Healthy

OCF (TTM) = $3.63B

Current Liabilities = $3.86B

Capex Coveragei

8.30x

Healthy

OCF (TTM) = $3.63B

CapEx (TTM) = $0.44B

E

Efficiency Metrics

⚡ Ratios calculated in USD to eliminate exchange rate impact

FCF/OCF Ratioi

87.95%

Healthy

FCF (TTM) = $3.19B

OCF (TTM) = $3.63B

Capex/Revenuei

3.63%

Healthy

CapEx (TTM) = $0.44B

Revenue (TTM) = $12.04B

Net Debt/EBITDAi

-0.25

Healthy

Net Debt = $-1.21B

EBITDA (TTM) = $4.91B

G

Growth Metrics

OCF Growthi

-14.81%

Attention

Current OCF (TTM) = $0.50B

Previous OCF = $0.58B

Owner Earningsi

$3.73B

Healthy

Net Income (TTM) = $3.95B

+ D&A (TTM) = $0.21B

- CapEx (TTM) = $-0.44B

加载图表中...

Loading...

Vertex Pharmaceuticals Incorporated

Investment Radar

🔍 Business Model Analysis (DuPont Model)

Leading Indicators

Financial Metrics

📊 Valuation

EV/EBITDA (TTM)

EV/EBIT (TTM)

EV/Sales (TTM)

P/E Ratio (TTM)

P/B Ratio (Quarterly)

FCF Yield (TTM)

PR Profit Ratio (PPM)

📈 Growth

Revenue (Quarterly)

Revenue/Share (Quarterly)

Net Income (Quarterly)

EPS (Quarterly)

Gross Profit/Share (Quarterly)

OCF/Share (Quarterly)

FCF/Share (Quarterly)

Operating Leverage (YoY)

💰 Profitability

Gross Margin (TTM)

Operating Margin (TTM)

Net Profit Margin (TTM)

ROE (TTM)

ROA (TTM)

ROTCE - Return on Tangible Common Equity (TTM)

OCF Margin (TTM)

FCF Margin (TTM)

💵 Cash Quality

OCF/NI Ratio (TTM)

FCF/NI Ratio (TTM)

OCF/Capex (TTM)

OCF/SBC (TTM)

🛡️ Leverage & Liquidity

Debt/Equity (quarterly)

EBITDA/Net Debt (TTM)

Interest Coverage (TTM)

Current Ratio (quarterly)

Quick Ratio (quarterly)

Altman Z-Score

⚙️ Ops & Cap Efficiency

ROIC (TTM)

ROCE - Return on Capital Employed (TTM)

Asset Turnover (TTM)

CapEx/Depreciation - Investment Intensity (TTM)

R&D/Gross Profit - R&D Intensity (TTM)

SG&A/Revenue - SG&A Efficiency (TTM)

Cash Conversion Cycle (TTM)

DSO - Days Sales Outstanding (TTM)

DIO - Days Inventory Outstanding (TTM)

DPO - Days Payables Outstanding (TTM)

Goodwill/Assets (Quarterly)

🎁 Shareholder Returns

Dividend Yield (TTM)

Buyback Yield (TTM)

Buyback Yield (3 Years)

Dilution Rate (1 Year)

Dilution Rate (3 Years)

SBC Offset Rate (TTM)

Insider Activity Rate (TTM)

Income Statement Analysis

Profit Waterfall Analysis

Balance Sheet Analysis

Cash Flow Statement Analysis

📊 Valuation

EV/EBITDA (TTM)

EV/EBIT (TTM)

EV/Sales (TTM)

P/E Ratio (TTM)

P/B Ratio (Quarterly)

FCF Yield (TTM)

PR Profit Ratio (PPM)

📈 Growth

Revenue (Quarterly)

Revenue/Share (Quarterly)

Net Income (Quarterly)